133 related articles for article (PubMed ID: 37406847)
1. Oral administration of procyanidin B2 3,3"-di-O-gallate ameliorates experimental autoimmune encephalomyelitis through immunosuppressive effects on CD4
Endo K; Sawa T; Tanaka Y; Saiki T; Haga H; Rizeq L; Aso H; Isono M; Niitsuma F; Masaki A; Makabe H; Tanaka S
Eur J Pharmacol; 2023 Sep; 954():175879. PubMed ID: 37406847
[TBL] [Abstract][Full Text] [Related]
2. Procyanidin B2 3,3″-di-O-gallate suppresses IFN-γ production in murine CD4
Endo K; Sawa T; Kitamura H; Umezawa K; Makabe H; Tanaka S
Int Immunopharmacol; 2023 Feb; 115():109617. PubMed ID: 36566519
[TBL] [Abstract][Full Text] [Related]
3. Procyanidin B2 gallate regulates TNF-α production from T cells through inhibiting glycolytic activity via mTOR-HIF-1 pathway.
Endo K; Matsui R; Sugiyama M; Asami T; Inaba C; Kobayashi S; Makabe H; Tanaka S
Biochem Pharmacol; 2020 Jul; 177():113952. PubMed ID: 32251675
[TBL] [Abstract][Full Text] [Related]
4. The suppression of IL-17 production from T cells by gallate-type procyanidin is mediated by selectively inhibiting cytokine production from dendritic cells.
Endo K; Matsui R; Asami T; Sawa T; Nakashima A; Tanaka Y; Makabe H; Tanaka S
Biomed Pharmacother; 2021 May; 137():111346. PubMed ID: 33556876
[TBL] [Abstract][Full Text] [Related]
5. Procyanidin B2 gallates inhibit IFN-γ and IL-17 production in T cells by suppressing T-bet and RORγt expression.
Tanaka S; Furuya K; Yamamoto K; Yamada K; Ichikawa M; Suda M; Makabe H
Int Immunopharmacol; 2017 Mar; 44():87-96. PubMed ID: 28088699
[TBL] [Abstract][Full Text] [Related]
6. Procyanidin B2 3,3''-di-O-gallate ameliorates imiquimod-induced skin inflammation by suppressing TLR7 signaling through the inhibition of endosomal acidification in dendritic cells.
Sawa T; Endo K; Nakashima A; Tanaka Y; Makabe H; Tanaka S
Int Immunopharmacol; 2023 Aug; 121():110444. PubMed ID: 37295030
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4
An K; Xue MJ; Zhong JY; Yu SN; Lan TS; Qi ZQ; Xia JJ
J Neuroinflammation; 2020 May; 17(1):147. PubMed ID: 32375831
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
9. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
10. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
13. Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR/microtubule pathway.
Wei Y; Li W; Huang J; Braunstein Z; Liu X; Li X; Deiuliis J; Chen J; Min X; Yang H; Gong Q; He L; Liu Z; Dong L; Zhong J
Theranostics; 2024; 14(3):1168-1180. PubMed ID: 38323310
[No Abstract] [Full Text] [Related]
14. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
15. Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Wang J; Chen F; Zheng P; Deng W; Yuan J; Peng B; Wang R; Liu W; Zhao H; Wang Y; Wu G
Exp Neurol; 2012 Jul; 236(1):79-87. PubMed ID: 22524989
[TBL] [Abstract][Full Text] [Related]
16. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
17. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
18. Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration.
Niu X; Sang H; Wang J
J Nutr Biochem; 2021 Mar; 89():108560. PubMed ID: 33249188
[TBL] [Abstract][Full Text] [Related]
19. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
[TBL] [Abstract][Full Text] [Related]
20. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
